TAK ALG-25 (Nesina 25 mg)
Generic Name: alogliptin
Pill with imprint TAK ALG-25 is Red, Elliptical / Oval and has been identified as Nesina 25 mg. It is supplied by Takeda Pharmaceuticals America, Inc..
Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TAK ALG-25
Nesina
- Generic Name:
- alogliptin
- Imprint:
- TAK ALG-25
- Strength:
- 25 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Takeda Pharmaceuticals America, Inc.
- National Drug Code (NDC):
- 64764-0250
More about Nesina (alogliptin)
- Nesina Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA Alerts (3)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
